Clinical TrialsSearch results
Number of results: 690
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Bio-signal measurement
- Understanding relationships between biosignals
- Yamashita Masaji
- 2023-07-07
Other
- Early Phase II clinical trial of PC-SOD -Study of the efficacy and safety of PC-SOD in patients with ulcerative colitis-
- Ulcerative colitis(UC-DAI:more than 4)
- LTT Bio-Pharma Co.,Ltd.
- 2007-06-27
Completed
- Phase 2 Dose-finding UC Study
- Ulcerative Colitis, Colitis, Ulcerative, IBD
- Ageishi Yuji
- 2021-08-30
Completed
- Open-label Extension Study of Brazikumab in Ulcerative Colitis
- Ulcerative Colitis
- Ageishi Yuji
- 2021-10-29
Recruiting
- Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants with Moderately to Severely Active Ulcerative Colitis.
- Ulcerative Colitis
- Yamazaki Hayato
- 2023-08-10
Recruiting
- Safety of rectal administration of a biocompatible synthetic peptide, PuraStat in Active Distal Ulcerative Colitis and Proctitis
- ulcerative colitis
- Nakase Hiroshi Nakase
- 2024-05-01
Recruiting
- A multicenter study to investigate Oral JAK inhibitor Pharmacogenomics and Exposure-Response relationship in Japanese adult patients with moderately to severely Active ulcerative colitis during the COVID-19 pandemic
- Ulcerative Colitis
- Fukudo Masahide
- 2021-08-23
Other
- Establishment of surveillance system for the longstanding ulcerative colitis patients Comparative study of efficacy for the targeted biopsy and the step biopsy
- Ulcerative colitis
- Teikyo University School of Medicine
- 2009-01-05
Other
- Post-marketing Clinical Trial of Pioglitazone - A Study of Preventive Effects on the Onset and Recurrence of Macrovascular Events -
- Type2 Diabetes
- Takeda Pharmaceutical Company Limited
- 2008-09-10
Other
- An open label multi facilities cooperation randomized control trial to verify postprandial hyperglycemia and hypertriglyceridemia improving effects of DIMS therapy in type 2 diabetes. reducing effect of olmesartan therapy in diabetic nephropathy.
- Type-2 diabetic patient who has been being hospitalized in our facilities is bedridden and takes liquid diet.
- Graduate School of Medicine,Tohoku University
- 2009-03-01